ResMed (RMD) Misses Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $189.69 +0.56%
Revenue Growth %: +13.1%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +13.1%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.60, $0.07 worse than the analyst estimate of $1.67. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.14 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
